The effect of a standardised ginseng extract in patients with moderate COPD: a randomised, double-blind trial

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/616609

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Chronic obstructive pulmonary disease (COPD) is a major cause of mortality and morbidity. Current medical treatments are only symptomatic and are far from satisfatory. Many COPD patients use herbal medicines but evidence of effect is lacking. This study will determine the effect and safety of a standardised extract of Panax ginseng for patients with moderate COPD. The design of the study will combine rigorous randomised controlled trial methodology with Chinese medicine theory.

Funded Activity Details

Start Date: 01-01-2010

End Date: 01-01-2015

Funding Scheme: NHMRC Project Grants

Funding Amount: $581,296.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Traditional Chinese Medicine and Treatments

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Ageing disease | Airway inflammation | Chronic obstructive pulmonary disease (COPD) | Complementary medicine | Herbal medicines | PGP1 | Quality of life | Randomised controlled trial

Related Links